Atara Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Thousand Oaks, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page
25
Current page
12
DEFA14A File 001-36548

DEFA14A

Filing date
07 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Mar 2023
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Mar 2023
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Mar 2023
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Mar 2023
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SCHEDULE 13G/A, AMENDMENT #2

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-253731

EFFECT filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Feb 2023
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SCHEDULE 13G/A

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-253731

POS AM

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-269647

S-8

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-253731

POSASR

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .